+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030- Product Image
Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030- Product Image
Sale

Global Microbiome Therapeutics Market by Type (Fecal Microbiota Transplantation, Microbiome Drugs, Probiotics & Prebiotics), Application (Autoimmune Diseases, Gastrointestinal Disorders, Infectious Diseases), End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674221
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Microbiome Therapeutics Market size was estimated at USD 131.09 million in 2023, USD 158.34 million in 2024, and is expected to grow at a CAGR of 21.44% to reach USD 510.87 million by 2030.

Microbiome therapeutics is an emergent area of medicine focused on using microorganisms or their components to prevent, treat, or cure disease. The human microbiome is the collection of trillions of commensal, symbiotic, and pathogenic microorganisms found in and on the human body. Microbiome therapeutics leverage the understanding of this complex ecosystem to develop products that can modify the microbiome in ways that contribute to health and combat disease. The market includes prebiotics, probiotics, postbiotics, and other interventions designed to treat and prevent diseases by influencing the microbiome.

An increase in the prevalence of lifestyle-associated diseases, greater understanding of the microbiome in human health and disease, advancements in microbiological research technologies, and a supportive regulatory environment have driven market growth. Despite the potential, the microbiome therapeutics market faces certain challenges, including a lack of standardized regulations, difficulties in proving the efficacy of certain products, and the complexity of the microbiome. Intellectual property issues, high research costs, and reimbursement challenges are additional challenges across the market. Tailoring treatments based on an individual's unique microbiome composition holds promise for therapies' efficacy and success rates. Advances in genomic and metagenomic analytics allow for precision modulation of the microbiome. Moreover, partnerships between pharmaceutical and biotech firms specializing in microbiome research are expanding, potentially leading to new therapeutic discoveries and applications.

Regional Insights

In North America, rising chronic disease prevalence and significant health consciousness among consumers have created a robust market for microbiome therapeutics. Advanced research facilities and substantial funding have led to groundbreaking microbial consortia and delivery technology patents. Key investments by major pharma and biotech firms and strategic partnerships propel the market across the region. EU nations collectively represent a vast market for microbiome therapeutics, underpinned by a strong regulatory framework and an emphasis on patient-centric care. Research and development are thriving, supported by European Commission initiatives like Horizon Europe.

The European Investment Bank has also actively financed high-potential startups in this sector. Interest in personalized medicine is expanding in the Middle East, albeit with varying degrees across the region. Lifestyle diseases are rising, prompting investments into novel treatments, including microbiome-based therapies. However, the regulatory landscape and market access differ greatly between countries, influencing customer purchasing behavior and market penetration. Africa's market for microbiome therapeutics is nascent but holds potential, primarily due to an increased burden of infectious and lifestyle diseases. The Asia-Pacific (APAC) region presents a rapidly growing market for microbiome therapeutics, fueled by rising healthcare awareness and an increasing prevalence of lifestyle diseases. Countries such as China and Japan are at the forefront, with both nations investing heavily in microbiome research. The APAC market is characterized by many start-ups and local companies venturing into microbiome therapeutics.

Market Trends by Segment

  • Type: Emerging significance of for fecal microbiota transplantation severe bacterial infections
  • Application: Increasing prevalence of infectious diseases driving the adoption of microbiome therapeutics
  • End-use: Expanding application of microbiome therapeutics in hospitals & clinics to established safety and efficacy profiles

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Ferring Signs Microbiome R&D Partnership Deal with PharmaBiome

Ferring Pharmaceuticals has forged a strategic research and development collaboration with PharmaBiome, a Swiss biotech firm specializing in microbiome technologies. The partnership focuses on advancing next-generation microbiome-based therapies for gastrointestinal conditions. Ferring has secured exclusive rights to develop, produce, and commercialize the novel biotherapeutics arising from this alliance, all of which will benefit from PharmaBiome's cutting-edge platform capable of crafting specific bacterial consortia with desired therapeutic activities, including the NicheMap and an innovative co-cultivation technique.

MaaT Pharma Joins Microbiome Therapeutics Innovation Group

MaaT Pharma has become a part of the Microbiome Therapeutics Innovation Group (MTIG), an alliance at the forefront of developing microbiome-based therapeutics. MaaT Pharma aligns seamlessly with MTIG's vision of transforming patient outcomes via regulatory and policy-driven solutions. The partnership converges MaaT Pharma's clinical progression with the joint expertise of MTIG's pioneering members, galvanizing efforts to convert extensive research into effective, FDA-approved treatments destined for clinical use.

FDA Approves Seres’ Microbiota Drug for Recurrent Gut Infection

The U.S. Food and Drug Administration has approved an innovative oral microbiome therapeutic by Seres Therapeutics designed to combat recurrent clostridioides difficile (C. diff.) infections. This therapeutic is crafted from thoroughly vetted human fecal matter, the drug encapsulates firmicutes spores essential for a robust microbiome that can deter C. diff colonization.

Key Company Profiles

The report delves into recent significant developments in the Microbiome Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alveolus Bio, Assembly Biosciences, Inc, Axial Therapeutics, Inc., BioGaia AB, Enterome SA, Ferring B.V., Intralytix, Inc., Kanvas Biosciences, Locus Biosciences, Inc., MaaT Pharma, Microba Group, Microbiotica Limited, Osel, Inc., PharmaBiome AG, Pylum Biosciences, Rebiotix Inc., Second Genome Inc., Seres Therapeutics, Inc., Servatus Limited, Synlogic Inc., Theriva Biologics, Inc., Vedanta Biosciences, Inc., Viome, and Yakult Honsha Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Microbiome Therapeutics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of lifestyle-associated diseases
5.1.1.2. Increasing use of microbiome sequencing capabilities for early disease detection and diagnosis
5.1.1.3. Rising focus towards the human microbiome therapeutics
5.1.2. Restraints
5.1.2.1. Lack of comprehensive research and limited expertise
5.1.3. Opportunities
5.1.3.1. Growing public funds and driving R&D related to microbiome therapeutics
5.1.3.2. Developing collaboration activities between pharmaceutical companies for the development of novel drugs
5.1.4. Challenges
5.1.4.1. Concerns associated with regulatory and standardization
5.2. Market Segmentation Analysis
5.2.1. Type: Emerging significance of for fecal microbiota transplantation severe bacterial infections
5.2.2. Application: Increasing prevalence of infectious diseases driving the adoption of microbiome therapeutics
5.2.3. End-use: Expanding application of microbiome therapeutics in hospitals & clinics to established safety and efficacy profiles
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Microbiome Therapeutics Market, by Type
6.1. Introduction
6.2. Fecal Microbiota Transplantation
6.3. Microbiome Drugs
6.4. Probiotics & Prebiotics
7. Microbiome Therapeutics Market, by Application
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Gastrointestinal Disorders
7.4. Infectious Diseases
7.5. Metabolic Disorders
8. Microbiome Therapeutics Market, by End-use
8.1. Introduction
8.2. Academic & Research Institutions
8.3. Hospitals & Clinics
9. Americas Microbiome Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Microbiome Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Microbiome Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Ferring Signs Microbiome R&D Partnership Deal with PharmaBiome
12.3.2. MaaT Pharma Joins Microbiome Therapeutics Innovation Group
12.3.3. FDA Approves Seres’ Microbiota Drug for Recurrent Gut Infection
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. MICROBIOME THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. MICROBIOME THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MICROBIOME THERAPEUTICS MARKET DYNAMICS
FIGURE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MICROBIOME THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. MICROBIOME THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MICROBIOME THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. CANADA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. MEXICO MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. INDIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 108. JAPAN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. THAILAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 160. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 161. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 164. DENMARK MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 165. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. EGYPT MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. FINLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. FRANCE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 188. GERMANY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. ITALY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 213. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. NORWAY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. POLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. QATAR MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. SPAIN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. TURKEY MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 285. MICROBIOME THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. MICROBIOME THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Alveolus Bio
  • Assembly Biosciences, Inc
  • Axial Therapeutics, Inc.
  • BioGaia AB
  • Enterome SA
  • Ferring B.V.
  • Intralytix, Inc.
  • Kanvas Biosciences
  • Locus Biosciences, Inc.
  • MaaT Pharma
  • Microba Group
  • Microbiotica Limited
  • Osel, Inc.
  • PharmaBiome AG
  • Pylum Biosciences
  • Rebiotix Inc.
  • Second Genome Inc.
  • Seres Therapeutics, Inc.
  • Servatus Limited
  • Synlogic Inc.
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Viome
  • Yakult Honsha Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 158.34 Million
Forecasted Market Value ( USD ) by 2030 $ 510.87 Million
Compound Annual Growth Rate21.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030 - Product Image

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030 - Product Image

Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers - Product Image

Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers

  • Report
  • 286 Pages
  • Global
From
Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] - Product Image

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]

  • Report
  • 209 Pages
  • Global
From
Microbiome Global Market Report 2024 - Product Image

Microbiome Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From

About the Microbiome Market

The Microbiome market is a subset of the biotechnology industry that focuses on the study of microbial communities and their interactions with the environment. It is a rapidly growing field, with research and development activities focusing on the development of new products and services that can be used to improve human health and the environment. Microbiome-based products and services are used in a variety of industries, including pharmaceuticals, food and beverage, agriculture, and cosmetics. The Microbiome market is driven by the increasing demand for personalized medicine, as well as the need for more efficient and cost-effective treatments for various diseases. Additionally, the development of new technologies, such as next-generation sequencing and metagenomics, has enabled researchers to better understand the composition and function of microbial communities. Companies in the Microbiome market include Second Genome, uBiome, Seres Therapeutics, and Enterome Bioscience. These companies are focused on developing products and services that can be used to improve human health and the environment. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.